(Q37906394)

25 August 2017

0 references

1 reference

title

MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis (English)

1 reference

25 August 2017

0 references

0 references

1 reference

parkinsonian syndrome

1 reference

1

1 reference

25 August 2017

Ernesto Cason

2

1 reference

25 August 2017

Antonella Stefanelli

3

1 reference

25 August 2017

Fabrizio Cocciolillo

4

1 reference

25 August 2017

Daniela Di Giuda

5

1 reference

25 August 2017

Giorgio Fagioli

6

1 reference

25 August 2017

Alessandro Giordano

7

1 reference

25 August 2017

publication date

27 July 2011

1 reference

Clinical Autonomic Research

25 August 2017

published in

1 reference

25 August 2017

volume

22

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

43-55

1 reference

Importance of 123I-metaiodobenzylguanidine scintigraphy/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromes

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Recent developments in innervation imaging using iodine-123-metaiodobenzylguanidine scintigraphy in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Neuronal imaging using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Meta-DiSc: a software for meta-analysis of test accuracy data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Cardiac MIBG scintigraphy in Primary Progressive Freezing Gait.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Myocardial MIBG scintigraphy: a useful clinical tool? : A retrospective study in 50 parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Cardiac 123I-MIBG scintigraphy in patients with essential tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Physiological changes in human cardiac sympathetic innervation and activity assessed by (123)I-metaiodobenzylguanidine (MIGB) imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10286-011-0135-5

Clinical and neuropathological correlates of Lewy body disease

21 January 2018

1 reference

12 December 2020

123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder

1 reference

12 December 2020

Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic.

1 reference

12 December 2020

Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy

1 reference

12 December 2020

Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis

1 reference

12 December 2020

Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy

1 reference

12 December 2020

Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies

1 reference

12 December 2020

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)

1 reference

12 December 2020

1 reference

12 December 2020

A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure

1 reference

12 December 2020

Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism

1 reference

12 December 2020

1 reference

12 December 2020

Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy

1 reference

12 December 2020

[123I] meta-iodobenzylguanidine myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease

1 reference

12 December 2020

Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.

1 reference

12 December 2020

Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders

1 reference

12 December 2020

Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value

1 reference

12 December 2020

Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp

1 reference

12 December 2020

Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation

1 reference

12 December 2020

10.1007/S10286-011-0135-5

Identifiers

DOI

1 reference

25 August 2017

1 reference